Definitive Contract 19AQMM20C0186

Award Date 9/23/20
Potential Completion Date 3/22/22
Potential Value $3.5M
Funding Federal Agency
Bureau of Medical Services
Contracting Federal Agency
Office of Acquisition Management
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20037, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of State Bureau of Medical Services (DOS) awarded a $475k definitive contract to Clinical Diagnostic Laboratories, LLC doing business as Clinical Diagnostic Lab for COVID-19 Laboratory Services. The firm fixed price contract will provide interim COVID-19 laboratory services from their Sterling, Virginia location from March 23, 2022 through June 30, 2022 to support DOS medical programs. As a leading clinical diagnostic laboratory, Clinical Diagnostic Lab will leverage their...
This is a firm fixed price purchase order awarded by the Department of State Bureau of Medical Services to Clinical Diagnostic Laboratories, LLC, a minority-owned, woman-owned small business, for laboratory testing services. The contract has a potential value of three hundred sixty-one thousand, five hundred seventy United States dollars ($361,570.00) and was awarded on July 15, 2020, with a completion date of July 14, 2021. The place of performance is in Vernon Hills, Illinois. No set-aside was...
This is a $91,693,500.00 firm-fixed-price definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company, for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025. Labcorp, a for-profit organization headquartered in Burlington, North Carolina, is the prime contractor and does not have any set-aside designation. The contract is not...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical laboratory products and diagnostics. The contract, valued at $77,990.25, is for the delivery of LAB PANELS with a period of performance through September 29, 2023. LGC Clinical Diagnostics has previously provided a variety of diagnostic testing services, validation testing, laboratory panels, control...
This is a delivery order awarded by the Department of the Army Medical Command to Laboratory Corporation of America (LabCorp), a leading global life sciences company, to provide COVID-19 clinical reference lab testing services. The firm fixed price contract, with a potential value of $349,092.19, has a completion date of February 28, 2021. LabCorp has extensive experience providing medical laboratory testing and analysis services to federal agencies, including the Department of Veterans Affairs,...
This is a firm-fixed price delivery order contract awarded to Laboratory Corporation of America (LabCorp) by the Defense Health Agency (DHA), a defense agency, for COVID-19 testing services. The contract has a total ceiling value of $1,800,000.00 and a period of performance ending on March 31, 2023. LabCorp is a leading global life sciences company with extensive experience providing diagnostic testing and reference laboratory services to federal agencies, including the Department of Veterans...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company. The contract, valued at $4,286,480.04, is part of the "Test Surge and Data Sharing" Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract, which is not set aside, will provide the CDC with a range of diagnostic testing services, including reference laboratory testing, genomic...
This is a firm fixed price delivery order contract awarded by the Defense Health Agency (DHA) to Laboratory Corporation of America (LabCorp) for $103,965.00 to provide clinical reference laboratory testing services. The contract has a completion date of March 31, 2021. LabCorp, a global life sciences company, has previously provided medical laboratory testing and analysis services to various federal agencies through its GSA Federal Supply Schedule contract and other indefinite...
This is a $240,000.00 firm fixed price delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Laboratory Corporation of America (LabCorp) for clinical reference laboratory testing services. The contract was awarded on April 1, 2020 and has a completion date of September 30, 2020. LabCorp is a global life sciences company that provides diagnostic information services and has a history of delivering laboratory testing services under federal contracts. No...
This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...

Clinical Diagnostic Laboratories, LLC, doing business as Clinical Diagnostic Lab, was awarded a $3.5 million firm-fixed-price definitive contract by the Department of State Bureau of Medical Services to provide on-site biological specimen collection and reverse transcriptase polymerase chain reaction testing for SARS-CoV-2. The one-year base period contract, with four one-year options, will support testing of approximately 180 personnel annually in the Washington, D.C. area through March 2022. This 100% small business set-aside award fulfills the Department's request for polymerase chain reaction COVID-19 testing support services under a best value tradeoff competition. Clinical Diagnostic Lab will deliver on-site and off-premises specimen collection and processing to detect the presence of the virus causing COVID-19, as initially outlined in the Department's August 2020 solicitation seeking these critical public health services.

Generated 12/29/23, 3:20 PM